RFP
AUPH icon

Root Financial Partners’s Aurinia Pharmaceuticals AUPH Stock Holding History

Root Financial Partners’s Portfolio AUPH Stock Details AUPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-811
Closed -$12K – 634
2026
Q1 		$12K Buy
+811
New +$11.9K ﹤0.01% 1585

Other funds holding AUPH

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
CAMG
CWA Asset Management Group Naples, Florida $3.28B AUM 34.07% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
CPC
Cookson Peirce & Co Pittsburgh, Pennsylvania $3.04B AUM 94.11% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
CG
Caprock Group Boise, Idaho $5.22B AUM 42.47% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
FHA
Flagship Harbor Advisors Boston, Massachusetts $2.61B AUM 23.21% 1-Year Est. Return
PFSRSONJ
Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return

Root Financial Partners's AUPH Position: Q2 2026 in Review

Root Financial Partners sold out of Aurinia Pharmaceuticals (AUPH) in Q2 2026, closing a stake of 811 shares — an estimated $12K sold.

Root Financial Partners first reported a position in AUPH in Q1 2026 and held it in 1 quarter. The position peaked at $12K in Q1 2026. 59 funds tracked by Wall St. Rank hold AUPH as of Q2 2026.

  • Root Financial Partners reported no remaining Aurinia Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
  • Root Financial Partners sold 811 Aurinia Pharmaceuticals shares in Q2 2026, an estimated $12K.
  • Root Financial Partners first reported a position in Aurinia Pharmaceuticals in Q1 2026 and held it in 1 quarter.
  • Root Financial Partners's Aurinia Pharmaceuticals position peaked at $12K in Q1 2026.
  • 59 funds tracked by Wall St. Rank held Aurinia Pharmaceuticals as of Q2 2026.

Based on Root Financial Partners's 13F filing for Q2 2026, filed 29 Jul 2026.